(R)-1-cyclopentyl-6-((1-morpholino-1-oxopropan-2-yl)amino)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one

ID: ALA4544864

PubChem CID: 155553114

Max Phase: Preclinical

Molecular Formula: C17H24N6O3

Molecular Weight: 360.42

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H](Nc1nc2c(cnn2C2CCCC2)c(=O)[nH]1)C(=O)N1CCOCC1

Standard InChI:  InChI=1S/C17H24N6O3/c1-11(16(25)22-6-8-26-9-7-22)19-17-20-14-13(15(24)21-17)10-18-23(14)12-4-2-3-5-12/h10-12H,2-9H2,1H3,(H2,19,20,21,24)/t11-/m1/s1

Standard InChI Key:  GESQMVSOZXARLD-LLVKDONJSA-N

Molfile:  

 
     RDKit          2D

 26 29  0  0  0  0  0  0  0  0999 V2000
    7.8422   -2.7081    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.8422   -3.5333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5550   -3.9398    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.5550   -2.2892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2637   -2.7081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2681   -3.5298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0513   -3.7782    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.5324   -3.1099    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.0440   -2.4512    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3158   -4.5586    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8327   -5.2297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3231   -5.8955    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1068   -5.6333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1022   -4.8080    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1275   -3.9449    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.4116   -3.5354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6970   -3.9470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4104   -2.7101    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9811   -3.5375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6982   -4.7723    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5550   -1.4639    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9779   -2.7157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2660   -2.3021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5490   -2.7144    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.5482   -3.5407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2645   -3.9547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  2  0
  3  6  1  0
  5  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 14 10  1  0
  7 10  1  0
  2 15  1  0
 15 16  1  0
 16 17  1  0
 16 18  1  1
 17 19  1  0
 17 20  2  0
  4 21  2  0
 19 22  1  0
 19 26  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4544864

    ---

Associated Targets(Human)

PDE1B Tclin Phosphodiesterase 1B (178 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE9A Tchem Phosphodiesterase 9A (1131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 360.42Molecular Weight (Monoisotopic): 360.1910AlogP: 0.89#Rotatable Bonds: 4
Polar Surface Area: 105.14Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 10.56CX Basic pKa: 1.69CX LogP: 0.12CX LogD: 0.11
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.84Np Likeness Score: -1.75

References

1. Wu Y, Zhou Q, Zhang T, Li Z, Chen YP, Zhang P, Yu YF, Geng H, Tian YJ, Zhang C, Wang Y, Chen JW, Chen Y, Luo HB..  (2019)  Discovery of Potent, Selective, and Orally Bioavailable Inhibitors against Phosphodiesterase-9, a Novel Target for the Treatment of Vascular Dementia.,  62  (8): [PMID:30916555] [10.1021/acs.jmedchem.8b01041]
2. Wu Y, Wang Q, Jiang MY, Huang YY, Zhu Z, Han C, Tian YJ, Zhang B, Luo HB..  (2021)  Discovery of Potent Phosphodiesterase-9 Inhibitors for the Treatment of Hepatic Fibrosis.,  64  (13.0): [PMID:34142552] [10.1021/acs.jmedchem.1c00862]

Source